Macular disease

The suppliers of two new anti-VEGF therapies recently cleared in the US that work to reduce macular disease treatment burdens...

The US Food and Drug Administration (FDA) has approved the Susvimo implant which delivers ranibizumab continuously, offering patients living with...

Prominent Melbourne retinal disease researcher Professor Robyn Guymer is encouraged by the Phase 3 results of a trial she’s been...

A clinical trial at Sydney Eye Hospital is evaluating the safety and efficacy of using infrared light to treat macular...

Eight Australian researchers are taking their projects to the next level with a share of more than $1 million in...

As part of Macula Month this May, Insight examines drug development programs that could significantly alter the late-stage AMD therapy...

Australia’s first clinical trials of an investigational gene therapy for dry age-related macular degeneration (AMD) has commenced at the Centre...

An independent expert panel has recommended Novartis' treatment Beovu be subsidised through the Pharmaceutical Benefits Scheme (PBS) for neovascular age-related...

Two years since the KeepSight launch, Insight asks what measurable difference this once-in-a-generation program is making to those living with...

A new diabetic eye clinic for children in Western Australia, which opened last month, is part of the Lions Eye Institute's first major...